IL2RA and myeloid sarcoma: To further solidify this concept, we analysed the expression of CD25 in a cross-sectional validation cohort of 30 untreated patients with RRMS and 29 genetically unrelated healthy donors14 (cohort of non-twins with MS) (Fig. 4e, Extended Data Table 1).